Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation-Reference-Cited by-同舟云学术

Combinations of isoform-targeted histone deacetylase inhibitors and bryostatin analogues display remarkable potency to activate latent HIV without global T-cell activation

Published:2017-08-07 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Albert Brice J.,Niu Austin,Ramani Rashmi,Marshall Garland R.,Wender Paul A.,Williams Robert M.,Ratner Lee,Barnes Alexander B.^ORCID,Kyei George B.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-07814-4.pdf

Reference62 articles.

1. Zhang, L. et al. Genetic characterization of rebounding HIV-1 after cessation of highly active antiretroviral therapy. J. Clin. Invest. 106, 839–845 (2000).

2. Chun, T. W. et al. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat. Med. 6, 757–761 (2000).

3. Siliciano, J. M. & Siliciano, R. F. The remarkable stability of the latent reservoir for HIV-1 in resting memory CD4+ T cells. J. Infect. Dis. 212, 1345–1347 (2015).

4. Davey, R. T. Jr et al. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc Natl Acad Sci USA 96, 15109–15114 (1999).

5. Archin, N. M., Sung, J. M., Garrido, C., Soriano-Sarabia, N. & Margolis, D. M. Eradicating HIV-1 infection: seeking to clear a persistent pathogen. Nat. Rev. Microbiol. 12, 750–64 (2014).

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Persistence, Latency, and Cure Approaches: Where Are We Now?;Viruses;2024-07-19

2. High concentrations of Maraviroc do not alter immunological and metabolic parameters of CD4 T cells;Scientific Reports;2024-06-17

3. A macrophage-cell model of HIV latency reveals the unusual importance of the bromodomain axis;Virology Journal;2024-04-05

4. Advances in structure-activity relationships of HDAC inhibitors as HIV latency-reversing agents;Expert Opinion on Drug Discovery;2024-01-23

5. Tuning spacer length improves the functionality of the nanobody-based VEGFR2 CAR T cell;BMC Biotechnology;2024-01-04